EUVIMEDEUVIMED entdecken
Crossref

Hyaluronic acid-modified core-shell structured cationic nanocarriers for posterior segment gene therapy

Jiayang Li, Tianyi Wang, Hao Chen, Xiaotong Zhou, Shujun Wang

Colloids and Surfaces B: Biointerfaces · 2026

DOI: 10.1016/j.colsurfb.2025.115367 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Colloids and Surfaces B: Biointerfaces, 2026. Verfasst von Jiayang Li und 4 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmacy, Shenyang Pharmaceutical University, Shenyang 110016, PR China. Hauptthemen laut MEDLINE: Hyaluronic Acid, Genetic Therapy, Nanoparticles, Drug Carriers. Die Arbeit nennt 31 Literaturangaben. Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Effective posterior eye gene delivery remains challenging for neovascular AMD treatment. We developed an intravitreal core-shell nanocarrier with a cationic PβAE dendrimer core (for DNA condensation/endosomal escape), biodegradable PLGA shell (sustained release), and surface HA (vitreal mobility/CD44 targeting). Optimized HA-PP/ND exhibited a uniform size (∼200 nm), high DNA encapsulation efficiency (98 %), and sustained release. In ARPE-19 cells, HA enhanced uptake, lysosomal escape, and transfection efficiency (4.3-fold higher luciferase expression). The carrier delivered antiangiogenic pFlt23K-EGFP, which suppressed VEGF by 48.5 % under hypoxia and inhibited endothelial migration/tube formation. Intravitreally administered HA-PP/N/D reduced CNV lesions by 68 % in a laser-induced wAMD mouse model. This multifunctional platform overcomes ocular gene delivery barriers, providing a promising non-viral strategy for treating posterior segment diseases.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hyaluronic AcidGenetic TherapyNanoparticlesDrug CarriersAnimalsHumansMiceCationsGene Transfer TechniquesTransfectionDNACell LinePolylactic Acid-Polyglycolic Acid CopolymerParticle SizeVascular Endothelial Growth Factor AChoroidal Neovascularization

Stichwörter der Autor:innen

Gene deliveryHyaluronic acidPLGA

Substanzen

Hyaluronic AcidCationsDNADrug CarriersPolylactic Acid-Polyglycolic Acid CopolymerVascular Endothelial Growth Factor A

Autor:innen und Institutionen

  • School of Pharmacy, Shenyang Pharmaceutical University, Shenyang 110016, PR China.
  • School of Pharmacy, Shenyang Pharmaceutical University, Shenyang 110016, PR China. Electronic address: wangshujun@syphu.edu.cn.

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Li, J., Wang, T., Chen, H., Zhou, X., & Wang, S. (2026). Hyaluronic acid-modified core-shell structured cationic nanocarriers for posterior segment gene therapy. Colloids and Surfaces B: Biointerfaces. https://doi.org/10.1016/j.colsurfb.2025.115367

Vancouver

Li J, Wang T, Chen H, Zhou X, Wang S. Hyaluronic acid-modified core-shell structured cationic nanocarriers for posterior segment gene therapy. Colloids and Surfaces B: Biointerfaces. 2026. doi:10.1016/j.colsurfb.2025.115367

BibTeX
@article{Li2026,
  author = {Li, Jiayang and Wang, Tianyi and Chen, Hao and Zhou, Xiaotong and Wang, Shujun},
  title = {Hyaluronic acid-modified core-shell structured cationic nanocarriers for posterior segment gene therapy},
  journal = {Colloids and Surfaces B: Biointerfaces},
  year = {2026},
  doi = {10.1016/j.colsurfb.2025.115367}
}
Kostenlos starten →